Niacin | Prediabetes Supplement Research

niacin diabetes diet supplement and metabolic syndrome managementNiacin prediabetes supplement science abstracts related to diabetes and pre-diabetes metabolic syndrome health.

Go to PubMed and copy the title in the search field.

Lipid control in patients with diabetes mellitus.

Safety review of combination drugs for hyperlipidemia.

Extended-release niacin/laropiprant lipid-altering consistency across patient subgroups.

The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol: Baseline characteristics of study participants. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: Impact on Global Health outcomes (AIM-HIGH) trial.

The Effect of Gemfibrozil, Niacin and Cholestyramine Combination Therapy on Metabolic Syndrome in the Armed Forces Regression Study.

Combination lipid therapy in type 2 diabetes mellitus.

Pleiotropic Effects of Nicotinic Acid: Beyond High Density Lipoprotein Cholesterol Elevation.

Triglycerides and atherogenic dyslipidaemia: extending treatment beyond statins in the high-risk cardiovascular patient.

Niacin results in reduced monocyte adhesion in patients with type 2 diabetes mellitus.

Recent advances in preventing cardiovascular disorders by managing lipid levels.

Treatment of dyslipidemia in patients with type 2 diabetes.

Adjunctive lipid lowering therapy in the era of surrogate endpoints.

Low high-density lipoprotein cholesterol: current status and future strategies for management.

Insights from recent meta-analysis: role of high-density lipoprotein cholesterol in reducing cardiovascular events and rates of atherosclerotic disease progression.

Share Button